Side Effects of Medical Cancer Therapy: Prevention and Treatment
Mario A. Dicato
Springer Science & Business Media, Dec 3, 2012 - Medical - 654 pages
This book is a comprehensive handbook designed for quick reference by medical oncologists on the side-effects of cancer therapy drugs, including the chemotherapeutic drugs. Organised by organ system, it will list the toxicity, side-effects and measures of prevention pertaining to each type of drug used in cancer therapy. The most dangerous side-effects will be given priority so as to alert the reader to their importance.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Gastrointestinal Cancer Selection of Clinically Relevant DrugInduced Toxicities Encountered in Gastrointestinal Cancer Treatment
Central Nervous System
Bone Marrow Toxicity Red Blood Cells
Preservation of Fertility in the Cancer Patient
Toxicity of BoneTargeted Agents in Malignancy
State of the Art of Antiemetic Therapy
Side Effects of Nociceptive Cancer Pain Treatments in Adults
Totally Implanted Access Ports Indications and Prevention of Complications
Other editions - View all
acute adjuvant administration adverse events agents anemia Ann Oncol anthracycline antibodies anticancer antiemetic aprepitant associated bevacizumab bisphosphonates blood bone breast cancer cancer patients Cancer Res carboplatin cardiac cardiotoxicity cardiovascular cell carcinoma cetuximab chemotherapy chemotherapy-induced chronic cisplatin Clin Oncol combination corticosteroids cyclophosphamide cytotoxic denosumab dexamethasone diarrhea disease dose doxorubicin drugs efficacy EGFR emesis Epub fluorouracil frequent G-CSF gastrointestinal gemcitabine grade growth factor guidelines gynecologic hematologic high-dose hypertension imatinib incidence increased induced infusion inhibition interactions intravenous lapatinib leukemia lung cancer lymphoma malignant meta-analysis metabolism metastatic methotrexate monitoring monoclonal myelosuppression nausea and vomiting neuropathy neutropenia Oncology opioids oral ovarian cancer paclitaxel pain patients receiving patients treated phase II study phase III trial prevention prolongation prostate cancer QTc interval radiotherapy randomized reactions receptor recommended recurrent regimen renal reported risk factors side effects skin sorafenib sunitinib symptoms syndrome tamoxifen targeted therapy tion toxicity trastuzumab treatment tumors zoledronic acid